DNA methylation-wide association study of prevalent and incident dementia in the US Health and Retirement Study

John F. Dou,Scarlet Cockell,Herong Wang,Nathan Hemenway,Lindsay H Ryan,Matt Zawistowski,E. Ware,K. Bakulski

Published 2025 in medRxiv

ABSTRACT

Abstract BACKGROUND: Peripheral blood DNA methylation may have utility as an early dementia risk biomarker. METHODS: We analyzed DNA methylation (blood collected 2016) and cognitive impairment in the Health and Retirement Study, a longitudinal study representative of US adults over age 50 (3,921 individuals and 585,356 CpG sites). We analyzed methylation associations with cognitive status both cross-sectionally and prospectively among participants with normal cognition at baseline with four years follow-up. RESULTS: Cross-sectionally, 5,322 CpGs were associated (pvalue<0.01) with cognitive impairment non-dementia, and 14,366 (166 genome-wide FDR<0.05) with dementia. Prospectively, 4,898 CpGs were associated with any-impairment. Enriched biologic pathways include ion transport, ligand-gated channel, and neuron differentiation. Nine CpGs overlapped all analyses including cg02583484 (HNRNPA1), cg15266133 (LOC102724084), cg24287460 (CCDC48), cg17124509 (C17orf57), and cg02553054 (SMARCD1). DISCUSSION: CpGs identified were enriched in pathways related to Alzheimers disease pathology and provide promising grounds for non-invasive blood biomarkers. Future studies for replication and with longer follow up are needed.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-59 of 59 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1